Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Patient-reported outcomes in NAFLD/NASH clinical trials: A blind spot that needs addressing.

PMID: 36536958
Journal: JHEP Reports
Year: 2023
Reference: JHEP Rep. 2022 Sep 22;5(1):100597. doi: 10.1016/j.jhepr.2022.100597. eCollection 2023 Jan.
Impact factor:
Publication type: Letter or abstract
Authors: Manzano-Nunez, Ramiro; Pericas, Juan M; Rivera-Esteban, Jesus; Sena, Elena et al.
DOI: 10.1016/j.jhepr.2022.100597

Patients with high cardiovascular risk as candidates to bempedoic acid after treatment with statins, ezetimibe and PCSK9 inhibitors. An estimation and cost-effectiveness analysis.

PMID: 36219195
Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
Year: 2023
Reference: J Cardiovasc Pharmacol. 2023 Jan 1;81(1):70-75. doi: 10.1097/FJC.0000000000001365.
Impact factor:
Publication type: Paper in international publication
Authors: Baneras, Jordi; Bello Mora, Maria C; Clemente Lorenzo, M Milagros; Cordero, Alberto; Cortez Quiroga, Gustavo A; Facila, Lorenzo; Fernandez Del Olmo, Rosa; Garcia, Pedro Blanch; Gonzalez-Juanatey, Jose R; Lopez-Rodriguez, Luis et al.
DOI: 10.1097/FJC.0000000000001365

Patritumab Deruxtecan in Untreated Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Final Results from Part A of the Window-of-Opportunity SOLTI TOT-HER3 Pre-Operative Study.

PMID: 37211044
Journal: ANNALS OF ONCOLOGY
Year: 2023
Reference: Ann Oncol. 2023 May 19:S0923-7534(23)00685-3. doi: 10.1016/j.annonc.2023.05.004.
Impact factor:
Publication type: Paper in international publication
Authors: Arumi, M; Cejalvo, J M; Ciruelos, E; Cruz, J; Esker, S; Espinosa-Bravo, M; Falato, C; Fan, P-D; Ferrero-Cafiero, J M; Gonzalez-Farre, B et al.
DOI: 10.1016/j.annonc.2023.05.004

Patterns of inflammation, microstructural alterations, and sodium accumulation define multiple sclerosis subtypes after 15 years from onset.

PMID: 37035717
Journal: Frontiers in Neuroinformatics
Year: 2023
Reference: Front Neuroinform. 2023 Mar 23;17:1060511. doi: 10.3389/fninf.2023.1060511. eCollection 2023.
Impact factor:
Publication type: Paper in international publication
Authors: Alexander, Daniel C; Brownlee, Wallace; Ciccarelli, Olga; Gandini Wheeler-Kingshott, Claudia A M; Golay, Xavier; Grussu, Francesco; Kanber, Baris; Prados, Ferran; Ricciardi, Antonio; Riemer, Frank et al.
DOI: 10.3389/fninf.2023.1060511

Patterns of response to anti-CGRP monoclonal antibodies during first 6-months of treatment in resistant migraine patients: impact on outcome.

PMID: 37038303
Journal: EUROPEAN JOURNAL OF NEUROLOGY
Year: 2023
Reference: Eur J Neurol. 2023 Jul;30(7):1937-1944. doi: 10.1111/ene.15816. Epub 2023 Apr 26.
Impact factor:
Publication type: Paper in international publication
Authors: Alpuente, Alicia; Caronna, Edoardo; Gallardo, Victor J; Gine-Cipres, Eulalia; Pozo-Rosich, Patricia; Torres-Ferrus, Marta et al.
DOI: 10.1111/ene.15816

Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial.

PMID: 37451291
Journal: LANCET ONCOLOGY
Year: 2023
Reference: Lancet Oncol. 2023 Jul 11:S1470-2045(23)00276-0. doi: 10.1016/S1470-2045(23)00276-0.
Impact factor:
Publication type: Paper in international publication
Authors: Albiges, Laurence; Atduev, Vagif; Barthelemy, Philippe; Climent, Miguel A; Ferguson, Thomas; Gedye, Craig; Gokmen, Erhan; Gurney, Howard; Lacombe, Louis; Lee, Chung-Han et al.
DOI: 10.1016/S1470-2045(23)00276-0

Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study.

PMID: 36055895
Journal: EUROPEAN UROLOGY
Year: 2023
Reference: Eur Urol. 2023 Jan;83(1):15-26. doi: 10.1016/j.eururo.2022.08.005. Epub 2022 Aug 30.
Impact factor:
Publication type: Paper in international publication
Authors: Arranz, Jose A; Augustin, Marinela; Carles, Joan; de Bono, Johann S; Fong, Peter C C; Gravis, Gwenaelle; Gurney, Howard; Heinzelbecker, Julia; Kolinsky, Michael P; Laguerre, Brigitte et al.
DOI: 10.1016/j.eururo.2022.08.005

Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study.

PMID: 36809080
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2023
Reference: J Clin Oncol. 2023 Apr 10;41(11):1992-1998. doi: 10.1200/JCO.22.01989. Epub 2023 Feb 21.
Impact factor:
Publication type: Paper in international publication
Authors: Bischoff, Helge G; Domine, Manuel; Esteban, Emilio; Felip, Enriqueta; Gadgeel, Shirish; Garassino, Marina C; Garon, Edward B; Gray, Jhanelle E; Grossi, Francesco; Hochmair, Maximilian J et al.
DOI: 10.1200/JCO.22.01989

Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial.

PMID: 37871604
Journal: LANCET
Year: 2023
Reference: Lancet. 2023 Oct 19:S0140-6736(23)02033-0. doi: 10.1016/S0140-6736(23)02033-0.
Impact factor:
Publication type: Paper in international publication
Authors: Albillos, Agustin; Ampuero, Javier; Andrade, Raul J; Angeli, Paolo; Arroyo, Vicente; Bai, Yuxian; Ballester, Maria Pilar; Belli, Luca; Berenguer, Marina; Berg, Thomas et al.
DOI: 10.1016/S0140-6736(23)02033-0

Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.

PMID: 36219809
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2023
Reference: J Clin Oncol. 2023 Feb 1;41(4):790-802. doi: 10.1200/JCO.21.02508. Epub 2022 Oct 11.
Impact factor:
Publication type: Paper in international publication
Authors: Baste, Neus; Brana, Irene; Bratland, Ase; Burtness, Barbara; de Castro, Gilberto Jr; Fuereder, Thorsten; Greil, Richard; Gumuscu, Burak; Harrington, Kevin J; Hughes, Brett G M et al.
DOI: 10.1200/JCO.21.02508

Penumbral Rescue by Normobaric O=O Administration in Patients with Ischemic Stroke and Target Mismatch ProFile (PROOF): Study Protocol of a Phase IIb Trial.

PMID: 37515459
Journal: International Journal of Stroke
Year: 2023
Reference: Int J Stroke. 2023 Jul 29:17474930231185275. doi: 10.1177/17474930231185275.
Impact factor:
Publication type: Paper in international publication
Authors: Adeyemi, Adedolapo Kamaldeen; Althaus, Katharina; Arenillas, Juan F; Audebert, Heinrich J; Baron, Jean-Claude; Bender, Benjamin; Benedikt, Frank; Broocks, Gabriel; Burghaus, Ina; Cardona, Pere et al.
DOI: 10.1177/17474930231185275

[Perceptions and external factors of physical activity in adolescents using mixed methods].

PMID: 36527841
Journal: Gaceta Sanitaria
Year: 2023
Reference: Gac Sanit. 2022 Dec 15;37:102281. doi: 10.1016/j.gaceta.2022.102281. eCollection 2023.
Impact factor:
Publication type: Paper in national publication
Authors: Lumillo-Gutierrez, Iris; Morin-Fraile, Victoria; Pla-Consuegra, Margarida; Rosa-Castillo, Antonio; Rosello-Novella, Alba; Villa-Garcia, Lorena et al.
DOI: 10.1016/j.gaceta.2022.102281

Perceptions of Food among College Students in the Field of Food Science: A Food Sustainability Approach.

PMID: 36900434
Journal: Foods
Year: 2023
Reference: Foods. 2023 Feb 21;12(5):917. doi: 10.3390/foods12050917.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilera, Mari; Celorio-Sarda, Ricard; Comas-Baste, Oriol; de Moraes Prata Gaspar, Maria Clara; Gomez, Maria Clara; Larrea-Killinger, Cristina; Soar, Claudia; Vidal-Carou, M Carmen et al.
DOI: 10.3390/foods12050917

Performance analysis of a STEMI network: prognostic impact of the type of first medical contact facility.

PMID: 36623690
Journal: REVISTA ESPANOLA DE CARDIOLOGIA
Year: 2023
Reference: Rev Esp Cardiol (Engl Ed). 2023 Sep;76(9):708-718. doi: 10.1016/j.rec.2022.12.010. Epub 2023 Jan 6.
Impact factor:
Publication type: Paper in national publication
Authors: Andrea, Rut; Ariza, Albert; Bayes-Genis, Antoni; Cardenas, Merida; Carrillo, Xavier; de Diego, Oriol; Fabrega, Xavier Jimenez; Faiges, Marta; Ferrer, Marc; Garcia-Garcia, Cosme et al.
DOI: 10.1016/j.rec.2022.12.010

Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study.

PMID: 36283826
Journal: THORAX
Year: 2023
Reference: Thorax. 2023 Mar;78(3):288-296. doi: 10.1136/thorax-2022-218929. Epub 2022 Oct 25.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez, Cristina; Baquero-Artigao, Fernando; Bell, Christine; Berhard-Stirnemann, Sara; Bilogortseva, Olga; Blazquez-Gamero, Daniel; Brinkmann, Folke; Buettcher, Michael; Buonsenso, Danilo; Bustillo-Alonso, Matilde et al.
DOI: 10.1136/thorax-2022-218929

Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.

PMID: 37379158
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2023
Reference: N Engl J Med. 2023 Jun 28. doi: 10.1056/NEJMoa2215530.
Impact factor:
Publication type: Paper in international publication
Authors: Aguado de la Rosa, Carlos; Aguilar, Andres; Barneto, Isidoro; Benitez, Raquel; Bernabe, Reyes; Bosch-Barrera, Joaquim; Calvo, Virginia; Camps, Carlos; Casal-Rubio, Joaquin; Cobo, Manuel et al.
DOI: 10.1056/NEJMoa2215530

Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.

PMID: 37386897
Journal: BRITISH JOURNAL OF HAEMATOLOGY
Year: 2023
Reference: Br J Haematol. 2023 Jun 30. doi: 10.1111/bjh.18941.
Impact factor:
Publication type: Paper in international publication
Authors: Baeza, Lourdes; Borrero, Juan Jose; Castellvi, Josep; Climent, Fina; Cordoba, Raul; Domingo-Domenech, Eva; Fraga, Maximo; Garcia-Cosio Piqueras, Monica; Gomez Codina, Jose; Gonzalez de Villambrosia, Sonia et al.
DOI: 10.1111/bjh.18941

Peritoneal transformation shortly after kidney transplantation in pediatric patients with preceding chronic peritoneal dialysis.

PMID: 36754369
Journal: NEPHROLOGY DIALYSIS TRANSPLANTATION
Year: 2023
Reference: Nephrol Dial Transplant. 2023 Sep 29;38(10):2170-2181. doi: 10.1093/ndt/gfad031.
Impact factor:
Publication type: Paper in international publication
Authors: Ariceta, Gema; Bartosova, Maria; Buscher, Rainer; Marinovic, Iva; Mehrabi, Arianeb; Oh, Jun; Ranchin, Bruno; Schaefer, Betti; Schmitt, Claus Peter; Schwab, Constantin et al.
DOI: 10.1093/ndt/gfad031

Perspectives toward the development of advanced materials based on bacterial polysaccharides.

PMID: 35770400
Journal: CURRENT MEDICINAL CHEMISTRY
Year: 2023
Reference: Curr Med Chem. 2023;30(17):1963-1970. doi: 10.2174/0929867329666220629152008.
Impact factor:
Publication type: Paper in international publication
Authors: Duran-Lara, Esteban F; Marican, Adolfo; Rafael, Diana; Vijayakumar, Sekar et al.
DOI: 10.2174/0929867329666220629152008

Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial.

PMID: 36066725
Journal: Gastric Cancer
Year: 2023
Reference: Gastric Cancer. 2023 Jan;26(1):123-131. doi: 10.1007/s10120-022-01335-4. Epub 2022 Sep 6.
Impact factor:
Publication type: Paper in international publication
Authors: Heeson, Sarah; Hoff, Paulo M; Kang, Yoon-Koo; Kiermaier, Astrid; Macharia, Harrison; Ohtsu, Atsushi; Restuccia, Eleonora; Shah, Manish A; Shen, Lin; Siddiqui, Asna et al.
DOI: 10.1007/s10120-022-01335-4

PET-based radiomics signature can predict durable responses to CAR T-cell therapy in patients with large B-cell lymphoma.

PMID: 38024636
Journal: EJHaem
Year: 2023
Reference: EJHaem. 2023 Sep 11;4(4):1081-1088. doi: 10.1002/jha2.757. eCollection 2023 Nov.
Impact factor:
Publication type: Paper in international publication
Authors: Abrisqueta, Pau; Balaguer-Montero, Maria; Barba, Pere; Bobillo, Sabela; Bosch, Francesc; Carpio, Cecilia; Clark, Joan; Cooper, Nichola; Ghanima, Waleed; Haenig, Jens et al.
DOI: 10.1002/jha2.757

Phage Therapy of Mycobacterium Infections: Compassionate-use of Phages in Twenty Patients with Drug-Resistant Mycobacterial Disease.

PMID: 35676823
Journal: CLINICAL INFECTIOUS DISEASES
Year: 2023
Reference: Clin Infect Dis. 2023 Jan 6;76(1):103-112. doi: 10.1093/cid/ciac453.
Impact factor:
Publication type: Paper in international publication
Authors: Belessis, Yvonne; Benson, Constance A; Cohen, Keira A; Cristinziano, Madison; Davidson, Rebecca M; Dedrick, Rebekah M; Freeman, Krista G; Gainey, Andrew; Garcia, Cristina Berastegui; Haidar, Ghady et al.
DOI: 10.1093/cid/ciac453

Pharmacoepidemiology: An Overview.

PMID: 38002647
Journal: Journal of Clinical Medicine
Year: 2023
Reference: J Clin Med. 2023 Nov 10;12(22):7033. doi: 10.3390/jcm12227033.
Impact factor:
Publication type: Paper in international publication
Authors: Blasi, Joan; Bong, David A; Coronel, Luis; D'Agostino, Maria Antonietta; Mandl, Peter; Martinoli, Carlo; Miguel-Perez, Maribel; Moller, Ingrid; Montane, Eva; Sabate, Monica et al.
DOI: 10.3390/jcm12227033

Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue.

PMID: 36765784
Journal: Cancers
Year: 2023
Reference: Cancers (Basel). 2023 Jan 29;15(3):826. doi: 10.3390/cancers15030826.
Impact factor:
Publication type: Paper in international publication
Authors: Beaulieu, Marie-Eve; Castillo Cano, Virginia; Foradada Felip, Laia; Kaur, Jastrinjan; Lopez-Estevez, Sergio; Martinez-Martin, Sandra; Masso-Valles, Daniel; Serrano Del Pozo, Erika; Soucek, Laura; Thabussot, Hugo et al.
DOI: 10.3390/cancers15030826

Publications